Differential regulation of the REGγ–proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells

REGγ is associated with multiple oncogenic pathways in human cancers

(2012) Jing He et al.   BMC CANCER

REGγ is a strong candidate for the regulation of cell cycle, proliferation and the invasion by poorly differentiated thyroid carcinoma cells

(2012) M. Zhang et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras

(2011) Sergio Acin et al.   JOURNAL OF PATHOLOGY

REGγ modulates p53 activity by regulating its cellular localization

(2010) Jian Liu et al.   JOURNAL OF CELL SCIENCE

REG gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell

(2010) Xiaoyi Wang et al.   MEDICAL ONCOLOGY

Identification of GRO1 as a Critical Determinant for Mutant p53 Gain of Function

(2009) Wensheng Yan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis

(2009) Giulia Fontemaggi et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Cabin1 restrains p53 activity on chromatin

(2009) Hyonchol Jang et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Suppression of Inhibitor of Differentiation 2, a Target of Mutant p53, Is Required for Gain-of-Function Mutations

(2008) W. Yan et al.   CANCER RESEARCH

TGFβ in Cancer

(2008) Joan Massagué   CELL

Proteasome activator PA28γ regulates p53 by enhancing its MDM2-mediated degradation

(2008) Zhuo Zhang et al.   EMBO JOURNAL

p53 Brings a New Twist to the Smad Signaling Network

(2008) A. Atfi et al.   Science Signaling